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ABSTRACT 
Meningiomas are generally slow-growing extra-axial benign tumours and in rare 
cases they can metastasize both neural and extra-neural. Intracranial meningiomas 
with leptomeningeal dissemination are extremely rare and the exact pathogenesis 
still remains unknown. The aim of this review is to analyse the pathways of 
intracranial and spinal metastatic spread of intracranial meningiomas and to discuss 
their particular clinical and pathological features. We highlight the fact that there is a 
possibility of leptomeningeal dissemination, even if cerebrospinal fluid cytology is 
negative, in patients with a medical history of a resected meningioma. We identified 
three possible ways of dissemination: haematogenous, through the CSF, or during 
surgery. From a histopathological point of view, the more malignant the meningioma, 
the more likely its leptomeningeal dissemination. 
 
INTRODUCTION 
Meningiomas are generally benign intracranial tumours and represent 
approximately 30% of all primary central nervous system tumours, with 
an incidence that has increased in recent years (1, 2, 3, 4, 5). Usually 
occurring on the surface of the brain as they originate in the arachnoid 
cells, meningiomas are generally slow-growing extra-axial benign 
tumours. In very rare cases, especially when the tumours become 
malignant, meningiomas can metastasize both in neural and extra-
neural sites (6). 
Only 0.1% of meningiomas are thought to metastasize (7), and 
usually these cases were atypical and anaplastic meningiomas (8, 9, 10), 
also known for their tendency to relapse after surgery (2, 11, 12, 13). 
Ather Enam et al. report an overall metastatic risk of 5% for atypical 
meningiomas and of 30% for anaplastic meningiomas (8), although 
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other authors consider these percentages to be 
overestimated (11, 14, 15). 
Meningiomas can metastasize in various organs 
(lung, liver, spleen, adrenal gland, thyroid, parotid 
gland) or bones, skin and deep soft tissue (16), but 
also in the intracranial or spinal space through 
cerebrospinal fluid (CSF) pathways. According to the 
existing literature, metastatic dissemination of 
meningiomas through CSF is a rare presentation (17, 
18, 19, 20, 21) and, since 1950, only 45 cases have 
been reported (22). Nevertheless, different other 
authors consider that the CSF dissemination risk of 
meningiomas is an uncommon event, as it may occur 
in 4% of metastasizing meningiomas (17, 23). 
However, the first historical description of 
leptomeningeal metastasis was made by Oliver in 
1837, followed by Eberth in 1870 (24, 25) Also, the 
first description of carcinoma cells in the CSF was 
realized by Dufour (26) and, in 1912, Berman was the 
first who used the term "meningeal carcinomatosis" 
(27). However, Kalm, in 1950, was the first who 
published a case of a malignant tentorium tumour, 
i.e. an anaplastic meningioma that metastasized in 
the medulla oblongata and in the leptomeningeal 
space (28). 
 
 
PATHWAYS OF METASTATIC SPREAD IN MENINGIOMAS 
Meningioma cells gain access to the subarachnoid 
space in several ways: haematogenous pathway, 
through the CSF, or during surgery. More frequently, 
the spread is haematogenous via the venous system 
and tumour cells gain access to the CSF through the 
dural sinuses or epidural plexus, especially in 
meningiomas that invade dural sinuses (29, 30). A 
 
 
 
FIGURE 1. Cerebrospinal fluid circulation: (1) superior sagittal sinus, (2) arachnoid granulation, (3) convexity subarachnoid space, 
(4) choroid plexus (site of CSF production), (5) lateral ventricle, (6) interventricular foramen (Monro), (7) third ventricle, (8) 
cerebral aqueduct (Sylvius), (9) fourth ventricle, (10) lateral aperture (foramen of Luschka), (11) median aperture (foramen of 
Magendie), (12) ventral subarachnoid space, (13) dorsal subarachnoid space. (Adapted after Ropper AH et al., Adams and 
Victor’s Principles of Neurology, 11th Edition) 
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second route of dissemination is by CSF with the 
tumour spreading throughout the neuroaxis (Figure 
1). 
In a review, Rawat et al. highlighted the fact that 
approximately 75% of patients with 
meningiomatous metastasis regardless of the route 
they followed have had previous operation for the 
primary tumour (31). Also, it was hypothesized that 
tumour cells gain access to the vascular channels 
and meningeal surface by seeding during surgery 
(32). Although this theory has earlier been rejected 
(33, 34), now it is accepted that surgical manipulation 
may release tumour cells into the CSF (30, 31). 
Metastatic spread during or after surgery exists 
theoretically, even though this theory is unlikely. But 
the incidence of leptomeningeal dissemination after 
meningiomas surgery is low and there are also cases 
with leptomeningeal dissemination through CSF 
without surgical intervention (35). Regarding 
malignant transformation of meningiomas after 
surgical resection, there is also the theoretical one 
(22). Koenig et al. reported that at the site of surgical 
injury, the growth factors can promote malignant 
changes inside the meningeal tumour (36) and this 
event was observed by Morantz and Shain in an 
experimental rat model (37). 
 
INTRACRANIAL AND SPINAL CORD DISSEMINATION 
THROUGH CSF PATHWAYS  
There are variable sites of meningioma metastasis 
through CSF pathways. The metastasis occurred due 
to leptomeningeal seeding from the neighboring 
meningioma, and the spinal canal is the second most 
common site (17) (Table 1).  
In literature, spinal metastasizing meningiomas 
are rarely reported (17, 38, 39, 40, 41). In spinal 
intradural dissemination, the tumour cells have a 
tendency to accumulate more frequently at dorsal 
nerve root level, especially in the medullary cone and 
cauda equine, probably due to directional active 
flowing of the CSF throughout the neuroaxis, and 
also to the effect of gravity (42, 43). In a large study 
on 200 consecutive meningiomas, of WHO grade I, 
which were followed prospectively during a median 
time of 8.5 years, Chamberlain and Glantz reported 
that 4 patients (2%) were diagnosed with spinal 
metastasis (21). Vries et al. also reported CSF or drop 
metastasis in 5% of non-benign meningiomas (44). 
Meningioma metastasis may be simultaneous, 
both in the intracranial space and in the spinal cord 
(17, 45). In 1992, Akimura et al. reported a malignant 
meningioma metastasizing through the CSF 
pathways, both in the cerebellopontine angle cistern 
and in the thoracic spinal cord. The primary tumour 
was a parasagittal malignant meningioma two-times 
operated, the second time for recurrence. At the first 
surgery, the frontal horn of the lateral ventricle was 
opened because the meningioma infiltrated into the 
deep frontal brain. The authors concluded that this 
artificial communication between the meningioma 
cavity and the CSF pathways enhanced the 
probability for tumour metastasis into 
cerebellopontine angle cistern and thoracic spinal 
cord (17).  
 
NEOPLASTIC MENINGITIS  
It is well known that neoplastic meningitis is more 
common with solid carcinoma such as lung, breast 
and gastrointestinal cancer (46), but literature also 
reported few malignant meningioma cases with CSF 
dissemination into the brain ventricles (47). There 
were only eight cases (47, 48) with intracranial or 
intraspinal malignant meningioma arising from low-
grade meningiomas, which disseminated 
throughout the CSF (47). In neoplastic meningitis, 
CSF dissemination of malignant meningioma cells 
may cause a variety of neurological symptoms such 
as disturbances of multiple cranial nerves, 
hydrocephalus, cerebellar dysfunction and multiple 
spinal nerve roots or cauda equine symptoms (49).  
Brainstem damage by CSF dissemination of 
malignant cell is rare, literature reporting a few cases 
with central hyperventilation, Wallenberg syndrome 
and diplopia, facial nerve palsy and unsteadiness of 
gait secondary of CSF dissemination of malignant 
tumour cells (20, 47, 50).  
It is important to mention, in terms of diagnosis, 
that only 54% of all cases with leptomeningeal 
meningiomatous dissemination revealed malignant 
cells in the CSF on initial lumbar puncture, and only 
8% of these cases remained negative, even after 
repeated examinations (51). The reason for this low 
specificity of the lumbar puncture remains unclear, 
although Fujimaki et al. speculate the fact that 
malignant cells adhere rather than float freely in the 
CSF (47). Although identification of malignant cells by 
CSF cytology has been considered the diagnostic 
gold standard, these paradigms have changed 
nowadays due to limited sensitivity of cytology. 
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HISTOPATHOLOGY OF CSF-DISSEMINATED MENINGIOMAS 
Even though the pathogenesis of CSF - disseminated 
meningiomas is not completely understood, over 
time researchers have issued various theories. In this 
regard, Engelhard proposed three different 
pathways of dissemination: (1) tumour cells could be 
"shed" away directly into the CSF due to direct 
contact between an anaplastic meningioma and CSF 
pathways; (2) tumour cells might invade the 
leptomeningeal space during its progression; 3) the 
tumour cells might be inoculated within the CSF at 
the time of the surgery (52). 
Other authors, such as Russel and Rubinstein, 
considered that tumour friability may play an 
important role in meningioma dissemination within 
CSF (42). However, considering that meningiomas 
arise from arachnoid cells and are naturally exposed 
to CSF during their growth, it is difficult to explain the 
scarcity of meningioma dissemination through CSF 
(22) as Chamberlain and Glantz reported that only 
4% of the meningiomas could present 
leptomeningeal dissemination and positive CSF 
cytology at the time of the diagnosis (21). 
More theoretically, the risk of intraventricular 
meningiomas to metastasize through CSF pathways 
should be high, but literature reports only nine cases 
of intraventricular meningiomas (22). As an 
explanation, Miller and Ramsden considered that the 
dynamics of the CSF pathways might prevent 
fragment formation and deposition of tumour cells 
(22, 53). However, in a review of 45 cases of 
meningioma with leptomeningeal dissemination 
through CSF, Park et al. noticed that the period of 
time needed for leptomeningeal dissemination in 
cases with intraventricular meningiomas is the 
shortest when compared to other intracranial and 
spinal meningiomas (22). 
All histological subtypes of meningiomas can 
metastasize (Table 1), even benign meningiomas (45, 
54, 55, 56, 57, 58), but meningeal tumours with 
clearly malignant features have a higher metastatic 
rate (59). Metastatic meningiomas are associated 
more frequently with aggressive meningiomas (WHO 
grade 2, and WHO grade 3), with a range of 
occurrence of 10-25% (21), i.e. the more malignant 
the meningioma, the more likely its leptomeningeal 
dissemination (9, 17, 41, 60).  
According to literature, from a histological point 
of view, several factors are predictive of meningioma 
metastasis, including high cellularity, nuclear 
pleomorphism (Figure 2), high mitosis rate, tumour 
necrosis, and invasion of blood vessels (7, 8). On the 
other hand, other authors consider that the 
metastasizing behaviour of these tumours is not 
correlated with their histological features (30, 31). 
 
 
 
 
 
FIGURE 2. Microphotographs of atypical meningioma, WHO 
grade II. A. A tumour made up of meningothelial cells arranged 
in a sheet-like pattern, with increased cellularity, 
pleomorphism, and areas with small cells having high 
Nucleus/Cytoplasm ratio (HE staining, x20); B. Ki67 labelling 
index has high values and indicates a malignant neoplasia 
(Anti-Ki67 antibody immunohistochemical staining, X40). 
 
CONCLUSION 
Intracranial meningiomas with CSF dissemination 
are extremely rare and, despite reports from 
literature, their pathogenesis remains unknown. In 
the case of a patient with a resected meningioma, 
the possibility of CSF dissemination of tumour cells 
should be borne in mind, even if CSF cytology is 
negative. Also, a spinal MRI should be performed, 
especially when spinal signs and symptoms are 
present.
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TABLE 1. Literature review of meningioma cases with CSF- dissemination 
 
Year of publication, 
Author 
Primary site 
of 
meningioma 
WHO 
Grade 
Intracranial 
metastasis 
Spinal 
metastasis 
Time to CSF 
disseminated 
disease  
2013, Tsuda et al. (43) T10-11 
intradural 
I →II - + 12 years 
2011, Wu et al. (61) Convexity III + - 1.7 years 
2011, Kim et al. (62) Posterior 
fossa 
III + - 0 
2011, Peng et al. (63) Medial 
temporal 
III + - 2 years 
2009, Kuroda et al. (64) Skull base I→II→II
I 
+ + 6.3 years 
2009, Eom et al. (6) Lateral 
ventricle 
II→III - + 1.3 years 
2008, Erkutlu et al. (65) Posterior 
fossa 
III - + 2.7 years 
2008, Santhosh et al. (65) Convexity III + + 9 months 
2007, Shintaku et al. (67) Lateral 
ventricle 
I→III + - 4.3 years 
2006, Chuang et al. (68) Convexity III - + 3 months 
2005, Cramer et al. (60) C1-C3 
intradural 
II - + 1.4 years 
2005, Al-Habib et al. (69) Not 
mentioned 
III + + 2 months 
2005, Chamberlain and 
Glantz (21) 
Not 
mentioned, 8 
cases 
I + (8 cases) + (6 cases) - 
2005, Wakabayashi et al. 
(70) 
Frontal 
convexity 
III + - 13 years 
2005, Koenig et al. (36) Temporal 
lobe 
III - + 1 month 
2005, Darwish et al. (71) Lateral 
ventricle 
II→III + + 7 months 
2002, Ramakrishnamurthy 
et al. (35) 
Lateral 
ventricle 
I + - 4 years 
2001, Conrad et al. (72) Convexity I→II→II
I 
+ + 6.4 years 
2000, Meinsma-VdTuin et al. 
(73) 
C2-C4 
intradural 
III + + 6 months 
2000, Lee et al. (74) Convexity III + + 9 years 
1998, Lee and Landy (41) Convexity 
Skull base 
Convexity 
III 
I 
III 
+ 
+ 
- 
+ 
+ 
+ 
1.5 years 
3.8 years 
8.5 years 
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1995, Peh and Fan (39) Lateral 
ventricle 
III + + 5 years 
1993, Greenberg et al. (75) Lateral 
ventricle 
III + + 2 months 
1992, Satoh et al. (18) Skull base I + + 0 
1992, Akimura et al. (17) Convexity III + + 1.8 years 
1989, Kamiya et al. (76) Lateral 
ventricle 
III - + 6 months 
1987, Strenger et al. (77) Third 
ventricle 
III + - 1.5 months 
1985, Kleinschmidt-
DeMasters and Avakian (20) 
Lateral 
ventricle 
III + + 1.7 years 
1975, Ludwin and Conley 
(78) 
Convexity III + + 10 months 
1972, Miller and Ramsden 
(53) 
Convexity III + - - 
1971, Riley et al. (22, 78)  Convexity I→III - + - 
1970, Shuanghoti et al. (22, 
78) 
Convexity III - + - 
1963, Russell et al. (22, 78) Skull base I + - - 
1960, Hoffman et al. (22, 78)  Convexity I→III + + - 
1954, Winkelman (22, 78) Skull base I + - - 
1950, Kalm (22, 78) Posterior 
fossa 
III + - - 
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